Table 1.
Baseline characteristics | INC | ODC | p-valuea |
---|---|---|---|
Number of patients (%) | 26 (45) | 32 (55) | |
Age y, median (IQ range) | 57 (52–64) | 61 (56–64) | 0.320 |
≥65 y, n (%) | 6 (23) | 7 (22) | 0.365 |
Males, n (%) | 21 (81) | 25 (78) | 0.412 |
BMI, kg/m2, n (%) | |||
<20 | 3 (12) | 6 (19) | 0.095 |
20–25 | 9 (35) | 15 (47) | 0.089 |
>25 | 14 (54) | 11 (34) | 0.869 |
Malnourished (PG-SGA BC), n (%) | 7 (27) | 14 (44) | 0.039 |
PEG, n (%) | 20 (78) | 31 (97) | 0.002 |
Tumor location, n (%) | |||
Oral cavity | 3 (12) | 3 (9) | 0.363 |
Oropharynx | 11 (43) | 13 (41) | 0.399 |
Hypopharynx | 4 (15) | 5 (16) | 0.292 |
Larynx | 5 (19) | 7 (22) | 0.236 |
Nasopharynx | 2 (8) | 4 (12) | 0.106 |
Unknown | 1 (4) | – | |
Stage, n (%) | |||
I | 1 (4) | 1(3) | 0.190 |
II | 2 (8) | 4 (12) | 0.106 |
III | 6 (23) | 6 (19) | 0.475 |
IV | 16 (62) | 21 (66) | 0.237 |
Unknown | 1 (4) | – | |
Stage III–IV, n (%) | 22 (85) | 27 (84) | 0.309 |
T Class, n (%) | |||
T1 | 7 (27) | 4 (12) | 0.816 |
T2 | 7 (27) | 8 (25) | 0.395 |
T3 | 6 (23) | 8 (25) | 0.269 |
T4 | 5 (19) | 12 (38) | 0.022 |
Unknown | 1 (4) | – | |
N Class, n (%) | |||
N0 | 9 (35) | 11(34) | 0.352 |
N1 | 3 (12) | 3 (9) | 0.363 |
N2 | 13 (50) | 18 (56) | 0.196 |
N3 | 1 (4) | – | |
Treatment plan, n (%) | |||
Surgery + chemoradiotherapy | 6 (23) | 5 (16) | 0.593 |
Surgery + radiotherapy | 1 (4) | 1 (3) | 0.190 |
Chemoradiotherapy | 16 (61) | 25 (78) | 0.036 |
Radiotherapy | 3 (12) | 1 (3) | 0.688 |
Smoking, pack years, n (%) | 17.5 (1–36) | 37.6 (12–54) | 0.013 |
Alcohol, drinks per week, n (%) | 2.5 (1–9) | 9 (1–21) | 0.088 |
IQ interquartile, BMI body mass index, PG-SGA, patient generated subjective global assessment; T, tumor; N, node; PEG, percutaneous gastrostomy; INC, intensive nutrition counseling; ODC, on-demand nutritional counseling. Data expressed as median (interquartile range) or number (%).
p-value Mann-Whitney or X2 test between INC and ODC group.